Fast and Sensitive HPLC-ESI-MS/MS Method for Etoricoxib Quantification in Human Plasma and Application to Bioequivalence Study

Fast and Sensitive HPLC-ESI-MS/MS Method for Etoricoxib Quantification in Human Plasma and Application to Bioequivalence Study

Etoricoxib is a non-steroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation. The objective of the current study was to develop a sensitive, fast and high-throughput HPLC-ESI-MS/MS method to measure etoricoxib levels in human plasma using a one-step methanol protein precipitation...

Full description

Bibliographic Details
Main Authors:	Gabriel Onn Kit Loh, Emily Yii Ling Wong, Yvonne Tze Fung Tan, Siew Chyee Heng, Mardiana Saaid, Kit Yee Cheah, Nurul Diyana Mohd Sali, Nair Damenthi, Sharon Shi Min Ng, Long Chiau Ming, Kok Khiang Peh
Format:	Article
Language:	English
Published:	MDPI AG 2022-09-01
Series:	Molecules
Subjects:	etoricoxib etoricoxib D4 protein precipitation high-sample throughput human plasma bioequivalence study
Online Access:	https://www.mdpi.com/1420-3049/27/17/5706

Similar Items

Etoricoxib Coated Tablets: Bioequivalence Assessment between Two Formulations Administered under Fasting Conditions
by: Jessica Meulman, et al.
Published: (2023-11-01)

ETORICOXIB: THERAPEUTIC POTENTIAL
by: A. E. Karateev
Published: (2009-03-01)

Etoricoxib‐induced pleural effusion: A case report
by: Bishal Kumar Sah, et al.
Published: (2023-11-01)

Complete form of pachydermoperiostosis with good initial response to etoricoxib: A case report
by: Abinash Baniya, et al.
Published: (2023-06-01)

Analgesia na entorse de tornozelo: estudo com etoricoxibe
by: Rogério Teixeira da Silva, et al.

Pharmacokinetic equivalence study of nonsteroidal anti-inflammatory drug etoricoxib
by: Tjandrawinata RR, et al.
Published: (2018-04-01)

Determination of etoricoxib in human plasma using automated on-line solid-phase extraction coupled with LC-APCI/MS/MS
by: Sérgio Luiz Dalmora, et al.
Published: (2008-01-01)

Pre-emptive 8 mg dexamethasone and 120 mg etoricoxib for pain prevention after periodontal surgery: A randomised controlled clinical trial
by: Kranti Konuganti, et al.
Published: (2015-01-01)

Etoricoxib (arcoxia) in rheumatology
by: Fatima Magomedovna Kudaeva, et al.
Published: (2011-06-01)

A case of wet purpura due to etoricoxib induced thrombocytopenia
by: Robin George Manappallil
Published: (2016-08-01)

Do etoricoxib and indometacin have similar effects and safety for gouty arthritis? A meta-analysis of randomized controlled trials
by: Lin TM, et al.
Published: (2018-12-01)

A simple Ultraviolet spectrophotometric method for the determination of etoricoxib in dosage formulations
by: Shipra Singh, et al.
Published: (2012-01-01)

Stability Study of Etoricoxib a Selective Cyclooxygenase-2 Inhibitor by a New Single and Rapid Reversed Phase HPLC Method
by: Muhammad Alzweiri, et al.
Published: (2018-07-01)

A case of toxic epidermal necrolysis probably due to etoricoxib
by: Sayanta Thakur, et al.
Published: (2019-01-01)

Formulation Development, Statistical Optimization, In Vitro and In Vivo Evaluation of Etoricoxib-Loaded Eucalyptus Oil-Based Nanoemulgel for Topical Delivery
by: Nabil A. Alhakamy, et al.
Published: (2021-08-01)

Etoricoxib-Cannabidiol Combo: Potential Role in Glioblastoma Treatment and Development of PLGA-Based Nanoparticles
by: Joanna Kuźmińska, et al.
Published: (2023-08-01)

Repairing effects of glucosamine sulfate in combination with etoricoxib on articular cartilages of patients with knee osteoarthritis
by: Yong Sun, et al.
Published: (2020-04-01)

LC-MS/MS assay of riluzole and etoricoxib in rat plasma and brain tissue with applications for sampling and evaluation in pre-clinical rat model of traumatic brain injury
by: Westley D. Eure, et al.
Published: (2021-12-01)

Etoricoxib in the treatment of osteoarthritis
by: S. G. Anikin, et al.
Published: (2020-03-01)

Formulation and Evaluation of Cox-2 Inhibitor (Etoricoxib) Loaded Ethyl Cellulose Nanoparticles for Topical Drug Delivery
by: Abbaraju Krishna Sailaja, et al.
Published: (2018-03-01)

Comparison of etoricoxib and indomethacin for the treatment of experimental periodontitis in rats
by: M.C.F. Azoubel, et al.
Published: (2007-01-01)

Novel analytical method based on chemometric models applied to UV–Vis spectrophotometric data for simultaneous determination of Etoricoxib and Paracetamol in presence of Paracetamol impurities
by: Mona A. Abdel Rahman, et al.
Published: (2023-12-01)

Evaluation of chemopreventive response of two cycloxygenase-2 inhibitors, etoricoxib and diclofenac in rat colon cancer using FTIR and NMR spectroscopic techniques Evaluación de la respuesta quimiopreventiva de dos inhibidores de la ciclooxigenasa 2, etoricoxib y diclofenaco en el cáncer de colon murino empleando las técnicas espectroscópicas FTIR Y NMR
by: M. Kaur Saini, et al.
Published: (2010-08-01)

Simultaneous determination of tramadol and paracetamol in human plasma using LC-MS/MS and application in bioequivalence study of fixed-dose combination
by: Gabriel Onn Kit Loh, et al.
Published: (2023-12-01)

Formulation and Evaluation of Etoricoxib Niosomes by Thin Film Hydration Technique and Ether Injection Method
by: Veldurthi Ravalika, et al.
Published: (2017-09-01)

Etoricoxib is safe and effective in preventing heterotopic ossification after primary total hip arthroplasty
by: Stella Oberberg, et al.
Published: (2021-02-01)

Development and Evaluation of Repurposed Etoricoxib Loaded Nanoemulsion for Improving Anticancer Activities against Lung Cancer Cells
by: Shadab Md, et al.
Published: (2021-12-01)

Eudragit®-S100 Coated PLGA Nanoparticles for Colon Targeting of Etoricoxib: Optimization and Pharmacokinetic Assessments in Healthy Human Volunteers
by: El-Maghawry E, et al.
Published: (2020-06-01)

Ascorbic Acid Ameliorates Cardiac and Hepatic Toxicity Induced by Azithromycin-Etoricoxib Drug Interaction
by: Reham Z. Hamza, et al.
Published: (2022-05-01)

Validated HPLC–PDA methodology utilized for simultaneous determination of Etoricoxib and Paracetamol in the presence of Paracetamol toxic impurities
by: Mona A. Abdel Rahman, et al.
Published: (2022-12-01)

Comparative evaluation of the safety and efficacy of etoricoxib and diclofenac on the upper gastrointestinal tract in patients with osteoarthrosis and rheumatoid arthritis (the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program)
by: L I Alekseyeva
Published: (2010-08-01)

Etoricoxib in the treatment of active sacroiliitis in patients with axial spondyloarthritis, including ankylosing spondylitis
by: I Z Gaĭdukova, et al.
Published: (2014-12-01)

Hipersensibilidad selectiva a inhibidores de la ciclooxigenasa-2
by: Laura Romero Sánchez, et al.
Published: (2023-01-01)

The efficacy and safety of etoricoxib versus meloxicam in the treatment of patients with gonarthrosis
by: B V Zavodovsky, et al.
Published: (2016-12-01)

Efficiency and safety of different etoricoxib regimens in patients with axial spondyloarthritis, including ankylosing spondylitis
by: I Z Gaydukova, et al.
Published: (2015-03-01)

ETORICOXIB IS A NEW SELECTIVE CYCLOOXYGENASE-2 INHIBITOR
by: A E Karateev
Published: (2009-06-01)

Effect of non-steroidal anti-inflammatory drug etoricoxib on the hematological parameters and enzymes of colon and kidney Efecto del fármaco antiinflamatorio no esteroideo etoricoxib sobre los parámetros hematológicos y las enzimas del colon y el riñón
by: N. Behal, et al.
Published: (2009-06-01)

Merging konjac glucomannan with other copolymeric hydrogels as a cutting-edge liquid raft system for dual delivery of etoricoxib and famotidine
by: Nabil A. Shoman, et al.
Published: (2023-12-01)

Synthesis of Copper Oxide-Based Nanoformulations of Etoricoxib and Montelukast and Their Evaluation through Analgesic, Anti-Inflammatory, Anti-Pyretic, and Acute Toxicity Activities
by: Sulaiman Sulaiman, et al.
Published: (2022-02-01)

Effects of various analgesics on pain perception and rate of tooth movement: a randomized controlled clinical study
by: Asem A Abdaljawwad, et al.
Published: (2022-06-01)